microRNA‑612 is downregulated by platelet‑derived growth factor‑BB treatment and has inhibitory effects on vascular smooth muscle cell proliferation and migration via directly targeting AKT2

Chen,Chen; Yan,Yan; Liu,Xiaodan

doi:10.3892/etm.2017.5428

microRNA‑612 is downregulated by platelet‑derived growth factor‑BB treatment and has inhibitory effects on vascular smooth muscle cell proliferation and migration via directly targeting AKT2

Authors:
- Chen Chen
- Yan Yan
- Xiaodan Liu
View Affiliations

Affiliations: Department of Cardiology, Affiliated Hospital of Binzhou Medical College, Binzhou, Shandong 256603, P.R. China, Emergency Centre, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, P.R. China, Department of Hematology, Affiliated Hospital of Binzhou Medical College, Binzhou, Shandong 256603, P.R. China
Published online on: November 1, 2017 https://doi.org/10.3892/etm.2017.5428
Pages: 159-165
Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Abnormal proliferation and migration of vascular smooth muscle cells (VSMCs) has been implicated in neointimal formation, and therefore is suggested to contribute to arteriosclerosis and restenosis. Previous studies have suggested that some microRNAs (miRs) serve crucial roles in VSMC proliferation and invasion; however, the underlying mechanism remains largely unknown. In the present study, it was demonstrated that treatment with platelet‑derived growth factor (PDGF)‑BB significantly promoted the proliferation and migration of VSMCs, and decreased miR‑612 levels in VSMCs. Overexpression of miR‑612 significantly inhibited PDGF‑BB‑induced migration and invasion of VSMCs, through inducing cell cycle arrest at G1 stage. AKT2 was further identified as a direct target gene of miR‑612, and its expression was negatively regulated by miR‑612 in VSMCs. Further investigation confirmed that overexpression of miR‑612 suppressed the PDGF‑BB‑induced upregulation of AKT2 protein expression. In conclusion, the present study demonstrated that miR‑612 is downregulated by PDGF‑BB treatment and has inhibitory effects on VSMC proliferation and migration via targeting AKT2. These findings suggest that miR‑612 may be used as a potential therapeutic candidate for neointimal formation in patients with atherosclerosis.

View Figures

View References

1	Yi N, Chen SY, Ma A, Chen PS, Yao B, Liang TM and Liu C: Tunicamycin inhibits PDGF-BB-induced proliferation and migration of vascular smooth muscle cells through induction of HO-1. Anat Rec (Hoboken). 295:1462–1472. 2012. View Article : Google Scholar : PubMed/NCBI
2	Zhang C: MicroRNA-145 in vascular smooth muscle cell biology: A new therapeutic target for vascular disease. Cell Cycle. 8:3469–3473. 2009. View Article : Google Scholar : PubMed/NCBI
3	Obata JE, Nakamura T, Kitta Y, Saito Y, Sano K, Fujioka D, Kawabata K and Kugiyama K: In-stent restenosis is inhibited in a bare metal stent implanted distal to a sirolimus-eluting stent to treat a long de novo coronary lesion with small distal vessel diameter. Catheter Cardiovasc Interv. 82:E777–E787. 2013. View Article : Google Scholar : PubMed/NCBI
4	Mazurova VV, Sukhorukov OE and Zakharova OV: Comparing moderately late results of the application of stents coated with a medicinal antiproliferative agent for the treatment of patients with various forms of coronary heart disease: Their efficacy and safety. Klin Med (Mosk). 90:30–35. 2012.(In Russian). PubMed/NCBI
5	Moss EG: MicroRNAs: Hidden in the genome. Curr Biol. 12:R138–R140. 2002. View Article : Google Scholar : PubMed/NCBI
6	Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
7	Zhou W, Zou B, Liu L, Cui K, Gao J, Yuan S and Cong N: MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4. Oncotarget. 7:74059–74073. 2016.PubMed/NCBI
8	Yao J, Deng B, Zheng L, Dou L, Guo Y and Guo K: miR-27b is upregulated in cervical carcinogenesis and promotes cell growth and invasion by regulating CDH11 and epithelial-mesenchymal transition. Oncol Rep. 35:1645–1651. 2016. View Article : Google Scholar : PubMed/NCBI
9	Ambros V: The functions of animal microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
10	Chen LJ, Lim SH, Yeh YT, Lien SC and Chiu JJ: Roles of microRNAs in atherosclerosis and restenosis. J Biomed Sci. 19:792012. View Article : Google Scholar : PubMed/NCBI
11	Weber C, Schober A and Zernecke A: MicroRNAs in arterial remodelling, inflammation and atherosclerosis. Curr Drug Targets. 11:950–956. 2010. View Article : Google Scholar : PubMed/NCBI
12	Liu X, Cheng Y, Zhang S, Lin Y, Yang J and Zhang C: A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res. 104:476–487. 2009. View Article : Google Scholar : PubMed/NCBI
13	Sun SG, Zheng B, Han M, Fang XM, Li HX, Miao SB, Su M, Han Y, Shi HJ and Wen JK: miR-146a and Krüppel-like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation. EMBO Rep. 12:56–62. 2011. View Article : Google Scholar : PubMed/NCBI
14	Tang J, Tao ZH, Wen D, Wan JL, Liu DL, Zhang S, Cui JF, Sun HC, Wang L, Zhou J, et al: MiR-612 suppresses the stemness of liver cancer via Wnt/β-catenin signaling. Biochem Biophys Res Commun. 447:210–215. 2014. View Article : Google Scholar : PubMed/NCBI
15	Sheng L, He P, Yang X, Zhou M and Feng Q: miR-612 negatively regulates colorectal cancer growth and metastasis by targeting AKT2. Cell Death Dis. 6:e18082015. View Article : Google Scholar : PubMed/NCBI
16	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
17	Lee J, Lim S, Song BW, Cha MJ, Ham O, Lee SY, Lee C, Park JH, Bae Y, Seo HH, et al: MicroRNA-29b inhibits migration and proliferation of vascular smooth muscle cells in neointimal formation. J Cell Biochem. 116:598–608. 2015. View Article : Google Scholar : PubMed/NCBI
18	Li TJ, Chen YL, Gua CJ, Xue SJ, Ma SM and Li XD: MicroRNA 181b promotes vascular smooth muscle cells proliferation through activation of PI3K and MAPK pathways. Int J Clin Exp Pathol. 8:10375–10384. 2015.PubMed/NCBI
19	Kim S and Kang H: miR-15b induced by platelet-derived growth factor signaling is required for vascular smooth muscle cell proliferation. BMB Rep. 46:550–554. 2013. View Article : Google Scholar : PubMed/NCBI
20	Gan J, Li P, Wang Z, Chen J, Liang X, Liu M, Xie W, Yin R and Huang F: Rosuvastatin suppresses platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferation and migration via the MAPK signaling pathway. Exp Ther Med. 6:899–903. 2013. View Article : Google Scholar : PubMed/NCBI
21	Guan S, Tang Q, Liu W, Zhu R and Li B: Nobiletin Inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration and attenuates neointimal hyperplasia in a rat carotid artery injury model. Drug Dev Res. 75:489–496. 2014. View Article : Google Scholar : PubMed/NCBI
22	Frias A, Lambies G, Viñas-Castells R, Martínez-Guillamon C, Dave N, García de Herreros A and Díaz VM: A switch in Akt isoforms is required for notch-induced Snail1 expression and protection from cell death. Mol Cell Biol. 36:923–940. 2015. View Article : Google Scholar : PubMed/NCBI
23	Shiratsuchi H and Basson MD: Akt2, but not Akt1 or Akt3 mediates pressure-stimulated serum-opsonized latex bead phagocytosis through activating mTOR and p70 S6 kinase. J Cell Biochem. 102:353–367. 2007. View Article : Google Scholar : PubMed/NCBI
24	Zhang W, Zhang X, González-Cobos JC, Stolwijk JA, Matrougui K and Trebak M: Leukotriene-C4 synthase, a critical enzyme in the activation of store-independent Orai1/Orai3 channels, is required for neointimal hyperplasia. J Biol Chem. 290:5015–5027. 2015. View Article : Google Scholar : PubMed/NCBI
25	Borst O, Münzer P, Gatidis S, Schmidt EM, Schönberger T, Schmid E, Towhid ST, Stellos K, Seizer P, May AE, et al: The inflammatory chemokine CXC motif ligand 16 triggers platelet activation and adhesion via CXC motif receptor 6-dependent phosphatidylinositide 3-kinase/Akt signaling. Circ Res. 111:1297–1307. 2012. View Article : Google Scholar : PubMed/NCBI
26	Rotllan N, Chamorro-Jorganes A, Araldi E, Wanschel AC, Aryal B, Aranda JF, Goedeke L, Salerno AG, Ramírez CM, Sessa WC, et al: Hematopoietic Akt2 deficiency attenuates the progression of atherosclerosis. FASEB J. 29:597–610. 2015. View Article : Google Scholar : PubMed/NCBI
27	Li Y, Yan L, Zhang W, Hu N, Chen W, Wang H, Kang M and Ou H: MicroRNA-21 inhibits platelet-derived growth factor-induced human aortic vascular smooth muscle cell proliferation and migration through targeting activator protein-1. Am J Transl Res. 6:507–516. 2014.PubMed/NCBI
28	Li P, Liu Y, Yi B, Wang G, You X, Zhao X, Summer R, Qin Y and Sun J: MicroRNA-638 is highly expressed in human vascular smooth muscle cells and inhibits PDGF-BB-induced cell proliferation and migration through targeting orphan nuclear receptor NOR1. Cardiovasc Res. 99:185–193. 2013. View Article : Google Scholar : PubMed/NCBI
29	Yang J, Chen L, Ding J, Fan Z, Li S, Wu H, Zhang J, Yang C, Wang H, Zeng P and Yang J: MicroRNA-24 inhibits high glucose-induced vascular smooth muscle cell proliferation and migration by targeting HMGB1. Gene. 586:268–273. 2016. View Article : Google Scholar : PubMed/NCBI
30	Tao ZH, Wan JL, Zeng LY, Xie L, Sun HC, Qin LX, Wang L, Zhou J, Ren ZG, Li YX, et al: miR-612 suppresses the invasive-metastatic cascade in hepatocellular carcinoma. J Exp Med. 210:789–803. 2013. View Article : Google Scholar : PubMed/NCBI